Company Profile

NATURAL CAPSULES LTD.

NSE : NABSE : 524654ISIN CODE : INE936B01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE125.853.1 (+2.53 % )
PREV CLOSE (Rs.) 122.75
OPEN PRICE (Rs.) 125.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 6381
TODAY'S LOW / HIGH (Rs.)114.00 126.95
52 WK LOW / HIGH (Rs.) 41.3 140
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 7.80372
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 1.39
ROCE (%) 3.71
Incorporation Year : 1993

Management Info :

C P Rangachar - Chairman Sunil L Mundra - Managing Director

Registered Office :

Address : Trident Towers,4th Floor, No. 23, 100 Feet Road,Jaynagar I I Block,
Bengaluru,
Karnataka-560011

Phone : 080- 26671571/ 26671573/ 26671581

Registrar's Details : Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE
NEWS More
25Feb02-25-2021$ Intimation For Approval Accorded Under PLI Scheme For M/S Natural Biogenex Private Limited, Wholly Owned Subsidiary Company Intimation For Approval Acc
This is to inform that M/s Natural Biogenex Private Limited, a wholly owned subsidiary of our Company has been approved to manufacture 3 bulk drugs viz, Betamethasone, Dexamethasone and Prednisolone under PLI (Production Linked Incentive) scheme as per attached Press Note of today issued by Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. Under this scheme, we will be eligible for a subsidy of 20% of the approved sales prices for 7 years starting from Financial year 2023-24.
This is to inform that M/s Natural Biogenex Private Limited, a..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit16.28.50000000000002
Gross Profit 22.6 13.7
Operating Profit 33.862.6
Net Sales 217.5615.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Gland Pharma (BSE)
 2764.25 (5.14%)
M.Cap ( in Cr)
45221.17
Astrazeneca Pharma I (BSE)
 3590.75 (3.89%)
M.Cap ( in Cr)
8976.88
Pfizer (BSE)
 5328.30 (2.09%)
M.Cap ( in Cr)
24375.76
Dr. Reddys Lab (BSE)
 4970.55 (1.58%)
M.Cap ( in Cr)
82660.86
Neuland Laboratories (BSE)
 2483.95 (2.32%)
M.Cap ( in Cr)
3186.88
Shareholding Pattern More
PROMOTERS 54.37 %
NON-INSTITUTION 45.63 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes